These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 12571633

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 8. Skin targeted DNA vaccine delivery using electroporation in rabbits. I: efficacy.
    Medi BM, Hoselton S, Marepalli RB, Singh J.
    Int J Pharm; 2005 Apr 27; 294(1-2):53-63. PubMed ID: 15814230
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery.
    Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG.
    Nat Med; 2002 Apr 27; 8(4):415-9. PubMed ID: 11927950
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome.
    Grinshtein N, Ventresca M, Margl R, Bernard D, Yang TC, Millar JB, Hummel J, Beermann F, Wan Y, Bramson JL.
    Cancer Gene Ther; 2009 Apr 27; 16(4):338-50. PubMed ID: 18989352
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
    Zhu ZB, Makhija SK, Lu B, Wang M, Kaliberova L, Liu B, Rivera AA, Nettelbeck DM, Mahasreshti PJ, Leath CA, Yamamoto M, Alvarez RD, Curiel DT.
    Gene Ther; 2004 Apr 27; 11(7):645-8. PubMed ID: 15029227
    [Abstract] [Full Text] [Related]

  • 17. A novel attenuated replication-competent adenovirus for melanoma therapy.
    Peter I, Graf C, Dummer R, Schaffner W, Greber UF, Hemmi S.
    Gene Ther; 2003 Apr 27; 10(7):530-9. PubMed ID: 12646858
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel DNA vaccine based on ubiquitin-proteasome pathway targeting 'self'-antigens expressed in melanoma/melanocyte.
    Zhang M, Obata C, Hisaeda H, Ishii K, Murata S, Chiba T, Tanaka K, Li Y, Furue M, Chou B, Imai T, Duan X, Himeno K.
    Gene Ther; 2005 Jul 27; 12(13):1049-57. PubMed ID: 15800663
    [Abstract] [Full Text] [Related]

  • 20. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
    Wolkersdörfer GW, Morris JC, Ehninger G, Ramsey WJ.
    J Gene Med; 2004 Jun 27; 6(6):652-62. PubMed ID: 15170736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.